2020 Q4 Form 10-Q Financial Statement

#000162828020016040 Filed on November 09, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q4
Revenue $650.0K $564.7K $0.00
YoY Change 13162.26% -100.0%
Cost Of Revenue $6.990M $2.815M $2.090M
YoY Change 234.45% 97.71% -81.19%
Gross Profit -$6.340M -$2.251M -$2.090M
YoY Change 203.35% 58.53% -81.15%
Gross Profit Margin -975.38% -398.53%
Selling, General & Admin $4.690M $5.950M $3.560M
YoY Change 31.74% 133.21% 30.88%
% of Gross Profit
Research & Development $4.020M $1.614M $3.980M
YoY Change 1.01% -1.58% 132.75%
% of Gross Profit
Depreciation & Amortization $240.0K $200.0K $100.0K
YoY Change 140.0% 100.0% 0.0%
% of Gross Profit
Operating Expenses $8.710M $7.565M $7.540M
YoY Change 15.52% 80.46% 70.2%
Operating Profit -$15.05M -$9.815M -$9.630M
YoY Change 56.28% 74.91% -37.95%
Interest Expense -$4.880M $74.32M -$5.560M
YoY Change -12.23% 1163.42% 155.05%
% of Operating Profit
Other Income/Expense, Net $322.3M $0.00 $15.85M
YoY Change 1933.12%
Pretax Income $302.3M -$84.13M $660.0K
YoY Change 45706.06% 631.98% -103.73%
Income Tax $21.83M $0.00
% Of Pretax Income 7.22%
Net Earnings $280.5M -$84.13M $660.0K
YoY Change 42396.97% 631.98% -103.73%
Net Earnings / Revenue 43150.77% -14898.12%
Basic Earnings Per Share -$0.78
Diluted Earnings Per Share $1.883M -$0.78 $9.916K
COMMON SHARES
Basic Shares Outstanding 120.5M shares 107.4M shares 66.86M shares
Diluted Shares Outstanding 107.4M shares

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $46.80M $80.20M $23.90M
YoY Change 95.82% 762.37% 1493.33%
Cash & Equivalents $46.82M $80.22M $23.87M
Short-Term Investments
Other Short-Term Assets $152.0K $13.00M $5.800M
YoY Change -97.38% 78.08% 152.17%
Inventory $15.47M $5.966M $1.798M
Prepaid Expenses
Receivables $1.037M $527.8K $7.921K
Other Receivables $100.0K $100.0K $0.00
Total Short-Term Assets $290.5M $99.71M $31.52M
YoY Change 821.62% 426.2% 394.87%
LONG-TERM ASSETS
Property, Plant & Equipment $11.40M $7.545M $6.830M
YoY Change 66.88% -15.45% 30.41%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $330.6M $13.10M $12.20M
YoY Change 2609.84%
Other Assets $94.70K
YoY Change
Total Long-Term Assets $342.0M $20.74M $19.15M
YoY Change 1685.77% 128.08% 252.39%
TOTAL ASSETS
Total Short-Term Assets $290.5M $99.71M $31.52M
Total Long-Term Assets $342.0M $20.74M $19.15M
Total Assets $632.5M $120.4M $50.67M
YoY Change 1148.26% 329.53% 329.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.791M $1.468M $1.679M
YoY Change 185.34% 47.44% -61.32%
Accrued Expenses $5.995M $4.296M $3.408M
YoY Change 75.91% 7.49% -13.64%
Deferred Revenue $1.413M $303.0K
YoY Change 366.17% -25.37%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $1.411M $862.3K $0.00
YoY Change -86.43%
Total Short-Term Liabilities $17.60M $132.1M $47.04M
YoY Change -62.59% 235.0% 148.71%
LONG-TERM LIABILITIES
Long-Term Debt $197.7M $548.7K $0.00
YoY Change -93.31% -100.0%
Other Long-Term Liabilities $207.0K $0.00
YoY Change
Total Long-Term Liabilities $207.0K $548.7K $0.00
YoY Change -93.31% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.60M $132.1M $47.04M
Total Long-Term Liabilities $207.0K $548.7K $0.00
Total Liabilities $237.3M $132.6M $85.59M
YoY Change 177.31% 178.44% 214.34%
SHAREHOLDERS EQUITY
Retained Earnings -$109.0M -$389.5M -$178.8M
YoY Change -39.02% 117.04% 26.31%
Common Stock $121.9K $115.0K $67.11K
YoY Change 81.69% 73.69% 15.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $395.2M -$12.19M -$34.91M
YoY Change
Total Liabilities & Shareholders Equity $632.5M $120.4M $50.67M
YoY Change 1148.26% 329.53% 329.27%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q4
OPERATING ACTIVITIES
Net Income $280.5M -$84.13M $660.0K
YoY Change 42396.97% 631.98% -103.73%
Depreciation, Depletion And Amortization $240.0K $200.0K $100.0K
YoY Change 140.0% 100.0% 0.0%
Cash From Operating Activities -$32.64M -$19.89M -$12.73M
YoY Change 156.4% 61.31% 188.01%
INVESTING ACTIVITIES
Capital Expenditures -$4.090M -$670.0K $1.990M
YoY Change -305.53% -34.95% 1709.09%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $3.650M
YoY Change -100.0% -100.0%
Cash From Investing Activities -$4.090M -$670.0K $5.650M
YoY Change -172.39% -34.95% 5036.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 197.7M 74.58M 21.79M
YoY Change 807.43% 667.25%
NET CHANGE
Cash From Operating Activities -32.64M -19.89M -12.73M
Cash From Investing Activities -4.090M -670.0K 5.650M
Cash From Financing Activities 197.7M 74.58M 21.79M
Net Change In Cash 161.0M 54.02M 14.71M
YoY Change 994.49% -504.34% -1100.68%
FREE CASH FLOW
Cash From Operating Activities -$32.64M -$19.89M -$12.73M
Capital Expenditures -$4.090M -$670.0K $1.990M
Free Cash Flow -$28.55M -$19.22M -$14.72M
YoY Change 93.95% 70.09% 224.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001425287
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37673
dei Entity Registrant Name
EntityRegistrantName
WORKHORSE GROUP INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1394771
dei Entity Address Address Line1
EntityAddressAddressLine1
100 Commerce Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Loveland
dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
45140
dei City Area Code
CityAreaCode
513
dei Local Phone Number
LocalPhoneNumber
360-4704
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
WKHS
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
120529157 shares
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80222741 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23868416 USD
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
0 USD
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
1000000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
41583 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
527796 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7921 USD
CY2020Q3 wkhs Finance Lease Receivable Current
FinanceLeaseReceivableCurrent
33100 USD
CY2019Q4 wkhs Finance Lease Receivable Current
FinanceLeaseReceivableCurrent
33100 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
5965710 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
1798146 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12959268 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4812088 USD
CY2019Q4 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
12194800 USD
CY2020Q3 wkhs Finance Lease Receivable Noncurrent
FinanceLeaseReceivableNoncurrent
134694 USD
CY2019Q4 wkhs Finance Lease Receivable Noncurrent
FinanceLeaseReceivableNoncurrent
129177 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
99708615 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
31519671 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7545291 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6830181 USD
CY2020Q3 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
13059700 USD
CY2020Q3 us-gaap Assets
Assets
120448300 USD
CY2019Q4 us-gaap Assets
Assets
50673829 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1467778 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1678983 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4295753 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3105184 USD
CY2020Q3 wkhs Warranty Liability
WarrantyLiability
3565942 USD
CY2019Q4 wkhs Warranty Liability
WarrantyLiability
6001864 USD
CY2020Q3 wkhs Warrant Liability
WarrantLiability
0 USD
CY2019Q4 wkhs Warrant Liability
WarrantLiability
16335000 USD
CY2020Q3 wkhs Customer Deposit Current
CustomerDepositCurrent
77000 USD
CY2019Q4 wkhs Customer Deposit Current
CustomerDepositCurrent
303000 USD
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
862278 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2020Q3 wkhs Convertible Debt Current Maturities At Fair Value
ConvertibleDebtCurrentMaturitiesAtFairValue
121817001 USD
CY2019Q4 wkhs Convertible Debt Current Maturities At Fair Value
ConvertibleDebtCurrentMaturitiesAtFairValue
19620000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
132085752 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
47044031 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
548722 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2020Q3 wkhs Convertible Debt Excluding Current Maturities At Fair Value
ConvertibleDebtExcludingCurrentMaturitiesAtFairValue
0 USD
CY2019Q4 wkhs Convertible Debt Excluding Current Maturities At Fair Value
ConvertibleDebtExcludingCurrentMaturitiesAtFairValue
19400000 USD
CY2020Q3 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent
SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent
0 USD
CY2019Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent
SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent
19142908 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
75000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
75000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
114963145 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
114963145 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67105000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67105000 shares
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
114964 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
67105 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
376111332 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
143826315 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-389512470 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-178806530 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1100000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-12186174 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-34913110 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
120448300 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50673829 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
564707 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4258 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
740949 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
373948 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
2815242 USD
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
1423904 USD
us-gaap Cost Of Revenue
CostOfRevenue
6074577 USD
us-gaap Cost Of Revenue
CostOfRevenue
3751674 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
-2250535 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
-1419646 USD
us-gaap Gross Profit
GrossProfit
-5333628 USD
us-gaap Gross Profit
GrossProfit
-3377726 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5950058 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2551406 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15464926 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6638350 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1614485 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1640454 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5133325 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4219456 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
7564543 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
4191860 USD
us-gaap Operating Expenses
OperatingExpenses
20598251 USD
us-gaap Operating Expenses
OperatingExpenses
10857806 USD
CY2020Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
0 USD
CY2019Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
0 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
864900 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
0 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
0 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9815078 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5611506 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-25066979 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-25066979 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-14235532 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
74315644 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
5882081 USD
us-gaap Interest Expense
InterestExpense
185638961 USD
us-gaap Interest Expense
InterestExpense
23582427 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-84130722 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11493587 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-210705940 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37817959 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-84130722 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-11493587 USD
us-gaap Net Income Loss
NetIncomeLoss
-210705940 USD
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.52
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.78
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.60
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
107406000 shares
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
66176921 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
83611526 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
63566295 shares
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-84130722 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-11493587 USD
us-gaap Net Income Loss
NetIncomeLoss
-210705940 USD
us-gaap Net Income Loss
NetIncomeLoss
-37817959 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-84130722 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11493587 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-209605940 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-37817959 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-27374629 USD
us-gaap Net Income Loss
NetIncomeLoss
-210705940 USD
us-gaap Net Income Loss
NetIncomeLoss
-37817959 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
574287 USD
CY2020Q3 wkhs Common Stock Issued For Payment Of Series B Preferred Stock Dividend Amount
CommonStockIssuedForPaymentOfSeriesBPreferredStockDividendAmount
491860 USD
CY2020Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
110242664 USD
CY2020Q3 wkhs Common Stock Dividends Common Stock Issued For Interest Payments On Convertible Notes Value
CommonStockDividendsCommonStockIssuedForInterestPaymentsOnConvertibleNotesValue
294798 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
738516 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-84130722 USD
CY2020Q3 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
0 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-12186174 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-34913110 USD
wkhs Stock Options And Warrants Exercised And Vesting Of Restricted Shares Value
StockOptionsAndWarrantsExercisedAndVestingOfRestrictedSharesValue
77811904 USD
wkhs Common Stock Issued For Payment Of Series B Preferred Stock Dividend Amount
CommonStockIssuedForPaymentOfSeriesBPreferredStockDividendAmount
1491860 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
148977683 USD
wkhs Common Stock Dividends Common Stock Issued For Interest Payments On Convertible Notes Value
CommonStockDividendsCommonStockIssuedForInterestPaymentsOnConvertibleNotesValue
1283695 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2767734 USD
us-gaap Net Income Loss
NetIncomeLoss
-210705940 USD
us-gaap Net Income Loss
NetIncomeLoss
-210705940 USD
us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
1100000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-12186174 USD
CY2019Q3 wkhs Stock Options And Warrants Exercised
StockOptionsAndWarrantsExercised
1973 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
334711 USD
CY2019Q3 wkhs Common Stock Issued For Payment Of Series B Preferred Stock Dividend Amount
CommonStockIssuedForPaymentOfSeriesBPreferredStockDividendAmount
166771 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-11493587 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-38364761 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-15422443 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5928235 USD
wkhs Stock Options And Warrants Exercised
StockOptionsAndWarrantsExercised
1973 USD
wkhs Exchange Offer Warrants Deemed Dividend
ExchangeOfferWarrantsDeemedDividend
0 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1211629 USD
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
857072 USD
us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
6709961 USD
wkhs Common Stock Issued For Payment Of Series B Preferred Stock Dividend Amount
CommonStockIssuedForPaymentOfSeriesBPreferredStockDividendAmount
166771 USD
us-gaap Net Income Loss
NetIncomeLoss
-37817959 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-38364761 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-70476795 USD
CY2020Q3 wkhs Stock Options And Warrants Exercised And Vesting Of Restricted Shares Value
StockOptionsAndWarrantsExercisedAndVestingOfRestrictedSharesValue
30653505 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2767734 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
291287 USD
wkhs Tooling Expense
ToolingExpense
350500 USD
wkhs Tooling Expense
ToolingExpense
0 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
850800 USD
wkhs Amortization Of Discount On Series Preferred Stock
AmortizationOfDiscountOnSeriesPreferredStock
5857092 USD
wkhs Amortization Of Discount On Series Preferred Stock
AmortizationOfDiscountOnSeriesPreferredStock
482589 USD
wkhs Change In Fair Value Convertible Notes
ChangeInFairValueConvertibleNotes
-163949684 USD
wkhs Change In Fair Value Convertible Notes
ChangeInFairValueConvertibleNotes
0 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
12176690 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
18935392 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
864900 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 USD
wkhs Payments For Preferred Stock Dividends Noncash
PaymentsForPreferredStockDividendsNoncash
-1491860 USD
wkhs Payments For Preferred Stock Dividends Noncash
PaymentsForPreferredStockDividendsNoncash
0 USD
wkhs Interest On Convertible Note Paid In Common Stock
InterestOnConvertibleNotePaidInCommonStock
1283695 USD
wkhs Interest On Convertible Note Paid In Common Stock
InterestOnConvertibleNotePaidInCommonStock
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1213602 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-41588 USD
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
525392 USD
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-33863 USD
wkhs Increase Decreasein Inventory
IncreaseDecreaseinInventory
4167564 USD
wkhs Increase Decreasein Inventory
IncreaseDecreaseinInventory
-122407 USD
wkhs Increase Decrease In Prepaid Deferred Expenses And Other Assets1
IncreaseDecreaseInPrepaidDeferredExpensesAndOtherAssets1
8147180 USD
wkhs Increase Decrease In Prepaid Deferred Expenses And Other Assets1
IncreaseDecreaseInPrepaidDeferredExpensesAndOtherAssets1
4538704 USD
wkhs Increase Decrease In Accounts Payable And Accrued Liabilities1
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities1
979364 USD
wkhs Increase Decrease In Accounts Payable And Accrued Liabilities1
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities1
-3128203 USD
wkhs Increase Decrease In Warranty
IncreaseDecreaseInWarranty
2435922 USD
wkhs Increase Decrease In Warranty
IncreaseDecreaseInWarranty
551798 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-226000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-72000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-37641992 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24137136 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1639897 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4001838 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
5000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1639897 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3996838 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
68925000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
1411000 USD
us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
5854140 USD
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
25000000 USD
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
0 USD
wkhs Proceeds From Issuance Of Series B Preferred Stock
ProceedsFromIssuanceOfSeriesBPreferredStock
0 USD
wkhs Proceeds From Issuance Of Series B Preferred Stock
ProceedsFromIssuanceOfSeriesBPreferredStock
25000000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
5928235 USD
wkhs Exercise Of Warrants And Options And Restricted Share Award Activity
ExerciseOfWarrantsAndOptionsAndRestrictedShareAwardActivity
49300214 USD
wkhs Exercise Of Warrants And Options And Restricted Share Award Activity
ExerciseOfWarrantsAndOptionsAndRestrictedShareAwardActivity
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
94636214 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
36782375 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
55354325 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8648401 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24868416 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1512750 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
80222741 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10161151 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
149000000.0 USD
CY2020Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
7310381 USD
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
3741097 USD
CY2020Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
526384 USD
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
422176 USD
CY2020Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0 USD
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0 USD
CY2020Q3 us-gaap Inventory Gross
InventoryGross
7836765 USD
CY2019Q4 us-gaap Inventory Gross
InventoryGross
4163273 USD
CY2020Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1871055 USD
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2365127 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
5965710 USD
wkhs Anti Dilution Feature Additional Shares Received Value
AntiDilutionFeatureAdditionalSharesReceivedValue
900000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
1798146 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
564707 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4258 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
740949 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
373948 USD
CY2020Q3 wkhs Paycheck Protection Program Term Note Cares Act
PaycheckProtectionProgramTermNoteCARESAct
1411000 USD
CY2019Q4 wkhs Paycheck Protection Program Term Note Cares Act
PaycheckProtectionProgramTermNoteCARESAct
0 USD
wkhs Class Of Warrant Or Right Additional Warrant Issuance Percentage Of Additional Equity Issuances
ClassOfWarrantOrRightAdditionalWarrantIssuancePercentageOfAdditionalEquityIssuances
0.10
CY2020Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
wkhs Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Percentage Of Issuance Price
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsPercentageOfIssuancePrice
1.10
wkhs Fair Value Measurement With Unobservable Inputs Reconciliation Change In Fair Value
FairValueMeasurementWithUnobservableInputsReconciliationChangeInFairValue
12200000 USD
CY2020Q3 wkhs Warrant Liability
WarrantLiability
0 USD
CY2019Q4 wkhs Warrant Liability
WarrantLiability
16300000 USD
CY2019Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P7Y
CY2020Q3 wkhs Common Stock Issued For Payment Of Series B Preferred Stock Dividend
CommonStockIssuedForPaymentOfSeriesBPreferredStockDividend
300000 shares
wkhs Common Stock Issued For Payment Of Series B Preferred Stock Dividend
CommonStockIssuedForPaymentOfSeriesBPreferredStockDividend
900000 shares
CY2020Q3 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
400000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1100000 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
8000000.0 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
6600000 shares
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
738516 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
334711 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2767734 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1211629 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-84130722 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-11493587 USD
us-gaap Net Income Loss
NetIncomeLoss
-210705940 USD
us-gaap Net Income Loss
NetIncomeLoss
-37817959 USD
CY2020Q3 us-gaap Dividends
Dividends
0 USD
CY2019Q3 us-gaap Dividends
Dividends
0 USD
us-gaap Dividends
Dividends
0 USD
us-gaap Dividends
Dividends
86207 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-84130722 USD
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11493587 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-210705940 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-37904166 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107406000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66176921 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83611526 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63566295 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107406000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
66176921 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83611526 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63566295 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5948219 shares
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
32917619 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5948219 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
32917619 shares

Files In Submission

Name View Source Status
0001628280-20-016040-index-headers.html Edgar Link pending
0001628280-20-016040-index.html Edgar Link pending
0001628280-20-016040.txt Edgar Link pending
0001628280-20-016040-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wkhs-20200930.htm Edgar Link pending
wkhs-20200930.xsd Edgar Link pending
wkhs-20200930xexx311.htm Edgar Link pending
wkhs-20200930xexx312.htm Edgar Link pending
wkhs-20200930xexx321.htm Edgar Link pending
wkhs-20200930xexx322.htm Edgar Link pending
wkhs-20200930_cal.xml Edgar Link unprocessable
wkhs-20200930_def.xml Edgar Link unprocessable
wkhs-20200930_htm.xml Edgar Link completed
wkhs-20200930_lab.xml Edgar Link unprocessable
wkhs-20200930_pre.xml Edgar Link unprocessable